Research in Social and Administrative Pharmacy
Volume 1, Issue 1 , Pages 101-117 , March 2005

The Authority/Pharmacotherapy Care model: an explanatory model of the drug use process in primary care⋆

  • Thomas R. Einarson, Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding author: Tel.: +1 416 978 6212; fax: +1 416 978 1833.

References 

  1. Brodie DC, Smith WE. Constructing a conceptual model of drug utilization review. Hospitals. 1976;50:143–144146, 148 passim
  2. Brodie DC. Drug utilization review—planning. Hospitals. 1972;46:103–112
  3. Crooks J. Methods of “audit” in drug use. In:  Duchene-Marullaz P editors. Advances in Pharmacology and Therapeutics. Proceedings of the Seventh International Congress of Pharmacology, Paris 1978. Oxford: Pergamon Press; 1979;p. 189–195
  4. Brodie DC, Smith WE, Hlynka JN. Model for drug usage review in a hospital. Am J Hosp Pharm. 1977;34:251–254
  5. Brodie DC, Lofholm P, Benson RA. A model for drug use review in a skilled nursing facility. J Am Pharm Assoc. 1977;17:617–620623
  6. Stolar MH. Model for a formal, prospective antibiotic use review program. Am J Hosp Pharm. 1978;35:809–811
  7. Pierpaoli PG, Coarse JF, Tilton RC. Antibiotic use control—an institutional model. Drug Intell Clin Pharm. 1976;10:258–267
  8. Rosman AW, Sawyer WT. Population-based drug use evaluation. Top Hosp Pharm Manage. 1988;8:76–92
  9. Lunde PK. Drug consumption surveys—a model for the analysis of health service?. Tidsskr Nor Laegeforen. 1978;98:1544–1545
  10. Chan KW, Walker AM, Yood RA. An equilibrium model of drug utilization. J Clin Epidemiol. 1993;46:113–121
  11. Donabedian A. The quality of care: how can it be assessed?. JAMA. 1988;260:1743–1748
  12. Titkow A. Illness behaviour and action: the patient role. Soc Sci Med. 1983;17:637–646
  13. Levine S, Kozloff MA. The sick role: assessment and overview. Ann Rev Sociol. 1978;4:317–343
  14. Bajcar J, Kenny N, Einarson TR. Patient care role of a consulting primary care pharmacist in a family physician office setting: an explanatory model. Res Soc Adm Pharm; submitted for publication.
  15. Paylor NR. The patient as caregiver. J Pastoral Care. 1984;38:91–97
  16. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management in primary care. JAMA. 2002;288:2469–2475
  17. Kessler RC, Berglund P, Demier O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105
  18. Lawton J. Lay experiences of health and illness: past research and future agendas. Sociol Health Illn. 2003;25:23–40
  19. Sempere-Selva T, Peiro S, Sendra-Pina P, Martinez-Espin C, Lopez-Aguilera I. Inappropriate use of an accident and emergency department: magnitude, associated factors, and reasons—an approach with explicit criteria. Ann Emerg Med. 2001;37:568–579
  20. Wagner PJ, Hendrich JE. Physician views on frequent medical use: patient beliefs and demographic and diagnostic correlates. J Fam Pract. 1993;36:417–422
  21. Andrade SE, Gurwitz JH, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Med Care. 1999;37:424–430
  22. Wilson K, Rosenberg MW. Accessibility and the Canadian health care system: squaring perceptions and realities. Health Policy. 2004;67:137–148
  23. Anderson M, Rosenberg MW. Ontario's underserviced area program revisited: an indirect analysis. Soc Sci Med. 1990;30:35–44
  24. Christiansen T, Pedersen KM, Harvald B, Rasmussen K, Jorgensen J, Svarer C. An investigation of the effect of regional variation in the treatment of hypertension. Soc Sci Med. 1989;28:131–139
  25. Ferguson RI, Maling TJ. The Nelson general practice prescribing project. Part I: a pilot audit of the regional prescribing profile. N Z Med. 1990;103:558–560
  26. Davis P, Gribben B. Rational prescribing and interpractitioner variation. a multilevel approach. Int J Technol Assess Health Care. 1995;11:428–442
  27. Melander E, Bjorgell A, Bjorgell P, Ovhed I, Molstad S. Medical audit changes physicians' prescribing of antibiotics for respiratory tract infections. Scand J Prim Health Care. 1999;17:180–184
  28. Gonzales R, Barrett PH, Crane LA, Steiner JF. Factors associated with antibiotic use for acute bronchitis. J Gen Intern Med. 1998;13:541–548
  29. Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A. Towards understanding treatment preferences of hospital physicians. Soc Sci Med. 1993;36:915–924
  30. Chinburapa V, Larson LN, Brucks M, Draugalis J, Bootman JL, Puto CP. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med. 1993;36:1473–1482
  31. Sleath B, Shih YC. Sociological influences on antidepressant prescribing. Soc Sci Med. 2003;56:1335–1344
  32. Sorensen TD, Biebighauser SM. Pharmaceutical care leadership: an innovative pharmacy practice residency model. J Am Pharm Assoc. 2003;43:527–532
  33. Pilnick A. “Patient counselling” by pharmacists: four approaches to the delivery of counselling sequences and their interactional reception. Soc Sci Med. 2003;56:835–849
  34. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218–226
  35. Prosser LA, Ray GT, O'Brien M, et al. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics. 2004;113:283–290
  36. Stuart B, Grana J. Ability to pay and the decision to medicate. Med Care. 1998;36:202–211
  37. Furler MD, Rolnick MS, Lawday KS, Mak MW, Einarson TR. Cost impact of switching histamine(2)-receptor antagonists to nonprescription status. Ann Pharmacother. 2002;36:1135–1141
  38. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999;33:281–288
  39. Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24:302–316
  40. Kuzujanakis M, Kleinman K, Rifas-Shiman S, Finkelstein JA. Correlates of parental antibiotic knowledge, demand, and reported use. Ambul Pediatr. 2003;3:203–210
  41. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002;36:1532–1539
  42. Einarson TR, Metge CJ, Iskedjian M, Mukherjee J. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study. Clin Ther. 2002;24:2126–2136
  43. Iskedjian M, Einarson TR. Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease. Pharmacoeconomics. 2003;21:115–127
  44. Hazra A, Tripathi SK, Alam MS. Prescribing and dispensing activities at the health facilities of a non-governmental organization. Natl Med J India. 2000;13:177–182
  45. Morgan DJ, Sutters CA, Pugh S. Medical audit and formulary management: a policy for rational use of thrombolytic drugs. Postgrad Med J. 1991;67:165–169
  46. Sylvia LM. A departmental model for drug-usage evaluation. Top Hosp Pharm Manage. 1991;11:46–52
  47. Sharp WT, Driver P, Bartlome P. Drug-usage evaluation: a system for the prospective evaluation of antibiotic utilization in minimum inhibitory concentration documented infections. Top Hosp Pharm Manage. 1991;11:59–69
  48. Brown NJ, Griffin MR, Ray WA, et al. A model for improving medication use in home health care patients. J Am Pharm Assoc. 1998;38:696–702
  49. Petitta A, Kaatz S, Estrada C, Effendi A, Anandan JV. The transition to medication system performance indicators. Top Hosp Pharm Manage. 1995;14:20–26
  50. Bunting RF. A model drug usage evaluation program. J Qual Assur. 1990;12:30–3350
  51. Lovejoy AE, Savage I. Prescribing analysis and cost tabulation (PACT) data: an introduction. Br J Community Nurs. 2001;6:62–67
  52. Kennie NR, Schuster BG, Einarson TR. Critical analysis of the pharmaceutical care research literature. Ann Pharmacother. 1998;32:17–26
  53. Carter BL, Malone DC, Billups SJ, et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 2001;58:1330–1337
  54. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20:1508–1516
  55. Baldwin RC, Anderson D, Black S, et al. Faculty of Old Age Psychiatry Working Group, Royal College of Psychiatrists. Guideline for the management of late-life depression in primary care. Int J Geriatr Psychiatry. 2003;18:829–838

PII: S1551-7411(04)00004-X

doi: 10.1016/j.sapharm.2004.12.003

Research in Social and Administrative Pharmacy
Volume 1, Issue 1 , Pages 101-117 , March 2005

Article Tools

* Image Usage & Resolution